OCULAR THERAPEUTIX, INC - Common Stock, $0.0001 par value per share (OCUL)

CUSIP: 67576A100

Q2 2017 13F Holders as of 30 Jun 2017

Type / Class
Equity / Common Stock, $0.0001 par value per share
Shares outstanding
218,782,791
Total 13F shares
15,456,517
Share change
-2,830,771
Total reported value
$143,279,882
Put/Call ratio
112%
Price per share
$9.27
Number of holders
71
Value change
-$26,251,504
Number of buys
35
Number of sells
37

Security key

67576A100

Report period

Q2 2017

Institutions

71

Top holders

10

Top shareholders of OCUL - OCULAR THERAPEUTIX, INC - Common Stock, $0.0001 par value per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
JENNISON ASSOCIATES LLC
13F
Company
1.5%
3,216,881
$29,853,000 31 Mar 2017
13F
Versant Venture Management, LLC
13F
Company
1%
2,215,384
$20,558,764 31 Mar 2017
13F
SV Health Investors, LLC
13F
Company
0.73%
1,605,207
$14,896,000 31 Mar 2017
13F
FMR LLC
13F
Company
0.62%
1,365,699
$12,674,000 31 Mar 2017
13F
WELLINGTON MANAGEMENT GROUP LLP
13F
Company
0.6%
1,312,703
$12,182,000 31 Mar 2017
13F
BlackRock Finance, Inc.
13F
Company
0.59%
1,290,745
$11,979,000 31 Mar 2017
13F
COLUMBUS CIRCLE INVESTORS
13F
Company
0.5%
1,087,605
$10,093,000 31 Mar 2017
13F
VANGUARD GROUP INC
13F
Company
0.41%
902,262
$8,373,000 31 Mar 2017
13F
MORGAN STANLEY
13F
Company
0.28%
604,636
$5,611,000 31 Mar 2017
13F
Opaleye Management Inc.
13F
Company
0.25%
550,000
$5,104,000 31 Mar 2017
13F
DELTEC ASSET MANAGEMENT LLC
13F
Company
0.18%
399,200
$3,705,000 31 Mar 2017
13F
Polaris Venture Management Co. V, L.L.C.
13F
Company
0.18%
383,141
$3,556,000 31 Mar 2017
13F
JPMORGAN CHASE & CO
13F
Company
0.17%
365,825
$3,394,000 31 Mar 2017
13F
STATE STREET CORP
13F
Company
0.15%
331,141
$3,076,000 31 Mar 2017
13F
NORTHERN TRUST CORP
13F
Company
0.11%
231,600
$2,149,000 31 Mar 2017
13F
ROYAL BANK OF CANADA
13F
Company
0.09%
197,705
$1,835,000 31 Mar 2017
13F
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
0.08%
175,361
$1,627,000 31 Mar 2017
13F
Schonfeld Strategic Advisors LLC
13F
Company
0.08%
169,628
$1,575,000 31 Mar 2017
13F
BAILARD, INC.
13F
Company
0.07%
146,752
$1,362,000 31 Mar 2017
13F
NOTTINGHAM ADVISORS, INC.
13F
Company
0.07%
144,446
$1,340,000 31 Mar 2017
13F
D. E. Shaw & Co., Inc.
13F
Company
0.06%
136,753
$1,269,000 31 Mar 2017
13F
DEUTSCHE BANK AG\
13F
Company
0.06%
133,632
$1,239,000 31 Mar 2017
13F
TIAA CREF INVESTMENT MANAGEMENT LLC
13F
Company
0.05%
110,234
$1,023,000 31 Mar 2017
13F
BRIDGEWAY CAPITAL MANAGEMENT, LLC
13F
Company
0.05%
100,000
$928,000 31 Mar 2017
13F
RENAISSANCE TECHNOLOGIES LLC
13F
Company
0.04%
88,900
$825,000 31 Mar 2017
13F
Bank of New York Mellon Corp
13F
Company
0.04%
88,736
$824,000 31 Mar 2017
13F
WELLS FARGO & COMPANY/MN
13F
Company
0.04%
87,046
$807,000 31 Mar 2017
13F
EDMOND DE ROTHSCHILD HOLDING S.A.
13F
Company
0.03%
70,000
$650,000 31 Mar 2017
13F
A.R.T. Advisors, LLC
13F
Company
0.02%
52,300
$485,000 31 Mar 2017
13F
SG Americas Securities, LLC
13F
Company
0.02%
49,024
$455,000 31 Mar 2017
13F
NEXT Financial Group, Inc
13F
Company
0.02%
48,203
$480,000 31 Mar 2017
13F
NewEdge Advisors, LLC
13F
Company
0.02%
47,250
$381,000 31 Mar 2017
13F
Virtu KCG Holdings LLC
13F
Company
0.02%
43,284
$402,000 31 Mar 2017
13F
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM
13F
Company
0.02%
41,839
$388,000 31 Mar 2017
13F
TEACHERS ADVISORS, LLC
13F
Company
0.02%
40,179
$373,000 31 Mar 2017
13F
Rhenman & Partners Asset Management AB
13F
Company
0.02%
40,000
$371,000 31 Mar 2017
13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC
13F
Company
0.02%
38,470
$358,000 31 Mar 2017
13F
BARCLAYS PLC
13F
Company
0.02%
33,227
$308,000 31 Mar 2017
13F
CORRADO ADVISORS, LLC
13F
Company
0.01%
32,805
$304,000 31 Mar 2017
13F
GOLDMAN SACHS GROUP INC
13F
Company
0.01%
31,995
$297,000 31 Mar 2017
13F
PARAMETRIC PORTFOLIO ASSOCIATES LLC
13F
Company
0.01%
30,582
$284,000 31 Mar 2017
13F
ALLIANCEBERNSTEIN L.P.
13F
Company
0.01%
27,300
$253,000 31 Mar 2017
13F
ALPS ADVISORS INC
13F
Company
0.01%
24,739
$230,000 31 Mar 2017
13F
RHUMBLINE ADVISERS
13F
Company
0.01%
22,428
$208,000 31 Mar 2017
13F
BANK OF MONTREAL /CAN/
13F
Company
0.01%
22,182
$206,000 31 Mar 2017
13F
Dynamic Technology Lab Private Ltd
13F
Company
0.01%
21,062
$195,000 31 Mar 2017
13F
Cutler Group LLC / CA
13F
Company
0.01%
20,247
$187,000 31 Mar 2017
13F
MANUFACTURERS LIFE INSURANCE COMPANY, THE
13F
Company
0.01%
15,089
$140,000 31 Mar 2017
13F
CREDIT SUISSE AG/
13F
Company
0.01%
13,257
$123,000 31 Mar 2017
13F
NEW YORK STATE COMMON RETIREMENT FUND
13F
Company
0.01%
12,801
$119,000 31 Mar 2017
13F

Institutional Holders of OCULAR THERAPEUTIX, INC - Common Stock, $0.0001 par value per share (OCUL) as of Q2 2017

As of 30 Jun 2017, OCULAR THERAPEUTIX, INC - Common Stock, $0.0001 par value per share (OCUL) was held by 71 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 15,456,517 shares. The largest 10 holders included Versant Venture Management, LLC, JENNISON ASSOCIATES LLC, SV Health Investors, LLC, BlackRock Inc., FMR LLC, WELLINGTON MANAGEMENT GROUP LLP, VANGUARD GROUP INC, COLUMBUS CIRCLE INVESTORS, MORGAN STANLEY, and STATE STREET CORP. This page lists 71 institutional shareholders reporting positions in this security for the Q2 2017 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q2 2017 vs Q1 2017 Across Filers

Q1 2017 holders
73
Q2 2017 holders
71
Holder diff
-2
Investor Q1 2017 Shares Q2 2017 Shares Share Diff Share Chg % Q1 2017 Value $ Q2 2017 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .